Max MyHealth Digital Platform & CSR Initiatives

4 MAX Healthcare Develop asset light adjacencies: Max Lab - Non-captive pathology SBU Organised diagnostics players to grow faster than overall Diagnostic industry India Diagnostic market to see steady growth (INR Bn) 11% CAGR 684 710 596 472 13-14% CAGR 1,360 Indian Diagnostic Industry mix by type of providers Multi-regional chains Standalone 46% 6% 11% Regional chains Operational footprint (as of Dec. 31, 2023) 525+ Partner-run collection centres FY17 FY18 FY20 Source: Axis Capital, Investec reports Net revenue (INR Cr) FY21 FY26E 37% Hospital based Shift to organised diagnostics centers driven by preference for higher quality and brands Investing for growth, 68% CAGR since FY17 EBITDA* (INR Cr) 23 Company owned collection centres (CoCC) ~160 Phlebotomist At Site (PAS) 275+ Pick-Up Points (PUPS) 112 106 5.0 50 12.4% 15% 104 4 +68% 1 3.0 5.5% 44 4.3% 9% 4.7 32 1.0% 66 1.0 1.4 1.8 3% HLMS & OLMS 0.3 -0.1 41 27 108 -0.9 105 -1.0 -3% -0.5% 24 72 -3.1% 13 -3.0 -9% 41 5 39 -5.0 -15% FY17 FY18 FY19 FY20 FY21 FY22 FY23 9M Q2 Q3 Q4 Q1 Q2 Q3 Cities of operations FY23 FY23 FY23 FY24 FY24 FY24 FY24 Non-COVID COVID-19 EBITDA EBITDA margin (%) Note: COVID-19 and related tests include RTPCR, Antigen, Antibody, CBNAAT, IL-6, D-Dimer, Ferritin, CRP, LDH, Procalcitonin Margin computed on net revenue, using arm length revenue share between Max Lab and hospitals (60:40 from FY23 onwards) for samples tested in hospital labs * 1,070+ Active Partners 21

View entire presentation